GlaxoSmithKline (GSK) agreed to settle 10,000 lawsuits alleging that its popular diabetes drug Avandia injured patients.
The settlements come as the Food and Drug Administration (FDA) begins two days of hearings into the safety of the drug. Earlier today, documents were released that suggested GSK hid data that showed Avandia increased the risk of heart attacks, heart failure and strokes.
For more information please contact 1877 MESSALAW.
No comments:
Post a Comment